| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(in millions, except per share data) | Quarter Ended December 31, 2023 | | Full-Year Ended December 31, 2023 |
| Acquired IPR&D and Milestones Expense | | Adjusted Diluted EPS Range | | Acquired IPR&D and Milestones Expense | | Adjusted Diluted EPS Range |
| | Low | | High | | | Low | | High |
Previously announced guidance excluding Q4 2023 acquired IPR&D and milestones expense | $ | — | | | $ | 2.87 | | | $ | 2.91 | | | $ | 496 | | | $ | 11.19 | | | $ | 11.23 | |
Q4 2023 acquired IPR&D and milestones expense | 282 | | | (0.15) | | | (0.15) | | | 282 | | | (0.15) | | | (0.15) | |
Guidance including Q4 2023 acquired IPR&D and milestones expense | $ | 282 | | | $ | 2.72 | | | $ | 2.76 | | | $ | 778 | | | $ | 11.04 | | | $ | 11.08 | |